Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

36Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bioengineered probiotics enable new opportunities to improve colorectal cancer (CRC) screening, prevention and treatment. Here, first, we demonstrate selective colonization of colorectal adenomas after oral delivery of probiotic E. coli Nissle 1917 (EcN) to a genetically-engineered murine model of CRC predisposition and orthotopic models of CRC. We next undertake an interventional, double-blind, dual-centre, prospective clinical trial, in which CRC patients take either placebo or EcN for two weeks prior to resection of neoplastic and adjacent normal colorectal tissue (ACTRN12619000210178). We detect enrichment of EcN in tumor samples over normal tissue from probiotic-treated patients (primary outcome of the trial). Next, we develop early CRC intervention strategies. To detect lesions, we engineer EcN to produce a small molecule, salicylate. Oral delivery of this strain results in increased levels of salicylate in the urine of adenoma-bearing mice, in comparison to healthy controls. To assess therapeutic potential, we engineer EcN to locally release a cytokine, GM-CSF, and blocking nanobodies against PD-L1 and CTLA-4 at the neoplastic site, and demonstrate that oral delivery of this strain reduces adenoma burden by ~50%. Together, these results support the use of EcN as an orally-deliverable platform to detect disease and treat CRC through the production of screening and therapeutic molecules.

References Powered by Scopus

Cancer Statistics, 2021

18247Citations
N/AReaders
Get full text

XCMS: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification

4001Citations
N/AReaders
Get full text

Pembrolizumab in microsatellite-instability-high advanced colorectal cancer

1854Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The challenge and opportunity of gut microbiota-targeted nanomedicine for colorectal cancer therapy

5Citations
N/AReaders
Get full text

Live bacterial therapeutics for detection and treatment of colorectal cancer

5Citations
N/AReaders
Get full text

Synthetic gene circuits as a promising approach in cancer immunotherapy

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., … Danino, T. (2024). Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-44776-4

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

38%

Researcher 8

31%

Professor / Associate Prof. 7

27%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 12

46%

Immunology and Microbiology 8

31%

Agricultural and Biological Sciences 3

12%

Medicine and Dentistry 3

12%

Article Metrics

Tooltip
Mentions
News Mentions: 7

Save time finding and organizing research with Mendeley

Sign up for free